Mechanistic Interplay of Gut Microbiota and Blood–Brain Barrier Integrity in Neurodegenerative Diseases
Authors:
- Suleiman Ibrahim MohammadSMSuleiman Ibrahim Mohammad
- Yasir Mohammed HammoodYHYasir Mohammed Hammood
- Asokan VasudevanAVAsokan Vasudevan
- Subasini UthirapathySubasini Uthirapathy
- Suhas BallalSBSuhas Ballal
- A. SabarivaniASA. Sabarivani
- Swati MishraSMSwati Mishra
- Deepak NathiyaDNDeepak Nathiya
- Abed J. KadhimAKAbed J. Kadhim
- 22 November 2025
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 137
Abstract
The gut microbiota, a diverse community of microorganisms residing in the gastrointestinal tract, plays a vital role in maintaining overall health through digestion, nutrient production, and immune modulation. Factors such as diet, lifestyle, and medication use significantly influence its composition. Concurrently, the blood–brain barrier (BBB) serves as a crucial protective barrier, regulating the passage of substances between the bloodstream and the brain. Disruption of the BBB is linked to various neurological disorders and cognitive decline. Neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s, can be exacerbated by compromised BBB integrity, allowing harmful substances to penetrate the brain and accelerate neuronal degeneration. This review examines the complicated relationship between gut microbiota and BBB integrity, focusing on their collective impact on neurodegenerative diseases. Despite advancements in understanding these systems independently, there remains a critical gap in comprehending their interconnected roles in neurodegeneration. Addressing this gap is paramount for developing innovative therapeutic strategies. Specifically, this review suggests that modulating the gut microbiota offers a promising and actionable approach to preserve BBB integrity, thereby presenting a novel avenue for mitigating neurodegeneration and improving the prognosis and quality of life for affected individuals.Keywords
This publication has 232 references indexed in Scilit:
- Neuropharmacology in the Molecular Epoch2025
- Explainable and Responsible AI in Neuroscience2025
- Nanoparticle-Based Biomarkers for Neurological Disorders2025
- Oligosaccharides from black ginseng innovatively prepared by low‐temperature steam‐heating process ameliorate cognitive impairment in Alzheimer's disease mice via the Keap‐1/Nrf2 pathwayJournal of the Science of Food and Agriculture, 2024
- Erythrocytic α‐Synuclein and the Gut Microbiome: Kindling of the Gut‐Brain Axis in Parkinson's DiseaseMovement Disorders, 2023
- Anti‐inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiotaPhytotherapy Research, 2022
- Perturbations in Gut Microbiota Composition in Psychiatric DisordersJAMA Psychiatry, 2021
- In Vitro Models of the Blood-Brain Barrier2020
- The power in numbers: Gut microbiota in Parkinson's diseaseMovement Disorders, 2014
- Gut microbiota are related to Parkinson's disease and clinical phenotypeMovement Disorders, 2014